July 19, 2012 / 7:47 AM / in 5 years

Roche gets U.S. approval for insulin pump system

ZURICH (Reuters) - The U.S. Food and Drug Administration (FDA) has given clearance for Roche’s new interactive insulin pump system for diabetics, the Swiss drugmaker said.

The system combines a blood glucose meter with an insulin pump which can exchange data in both directions via wireless technology and allows the insulin pump to be operated remotely, Roche said in a statement late on Wednesday.

The FDA clearance was the second for a diabetes product this year for Roche, the world leader in the blood glucose monitoring market with its Accu-Chek brand. In January, the FDA approved a new Accu-Chek blood glucose monitoring system.

Reporting by Emma Thomasson; Editing by David Cowell

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below